Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 145 No. 1920 (2015)

Acute painful diabetic neuropathy: an uncommon, remittent type of acute distal small fibre neuropathy

  • Christel Tran
  • Jacques Philippe
  • François Ochsner
  • Thierry Kuntzer
  • André Truffert
DOI
https://doi.org/10.4414/smw.2015.14131
Cite this as:
Swiss Med Wkly. 2015;145:w14131
Published
03.05.2015

Summary

INTRODUCTION: Acute painful diabetic neuropathy (APDN) is a distinctive diabetic polyneuropathy and consists of two subtypes: treatment-induced neuropathy (TIN) and diabetic neuropathic cachexia (DNC). The characteristics of APDN are (1.) the small-fibre involvement, (2.) occurrence paradoxically after short-term achievement of good glycaemia control, (3.) intense pain sensation and (4.) eventual recovery. In the face of current recommendations to achieve quickly glycaemic targets, it appears necessary to recognise and understand this neuropathy.

METHODS AND RESULTS: Over 2009 to 2012, we reported four cases of APDN. Four patients (three males and one female) were identified and had a mean age at onset of TIN of 47.7 years (±6.99 years). Mean baseline HbA1c was 14.2% (±1.42) and 7.0% (±3.60) after treatment. Mean estimated time to correct HbA1c was 4.5 months (±3.82 months). Three patients presented with a mean time to symptom resolution of 12.7 months (±1.15 months). One patient had an initial normal electroneuromyogram (ENMG) despite the presence of neuropathic symptoms, and a second abnormal ENMG showing axonal and myelin neuropathy. One patient had a peroneal nerve biopsy showing loss of large myelinated fibres as well as unmyelinated fibres, and signs of microangiopathy.

CONCLUSIONS: According to the current recommendations of promptly achieving glycaemic targets, it appears necessary to recognise and understand this neuropathy. Based on our observations and data from the literature we propose an algorithmic approach for differential diagnosis and therapeutic management of APDN patients.

References

  1. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29(7):1518–22.
  2. Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521–34.
  3. Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve. 2002;25(4):477–91.
  4. Caravati C. Insulin neuritis: a case report. Va Med Mon. 1933;59:745–6.
  5. Llewelyn JG, Thomas PK, Fonseca V, King RH, Dandona P. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol. 1986;72(2):157–63.
  6. Vital C, Vital A, Dupon M, Gin H, Rouanet-Larriviere M, Lacut JY. Acute painful diabetic neuropathy: two patients with recent insulin-dependent diabetes mellitus. J Peripher Nerv Syst. 1997;2(2):151–4.
  7. Wilson JL, Sokol DK, Smith LH, Snook RJ, Waguespack SG, Kincaid JC. Acute painful neuropathy (insulin neuritis) in a boy following rapid glycemic control for type 1 diabetes mellitus. J Child Neurol. 2003;18(5):365–7.
  8. Guldiken S, Guldiken B, Arikan E, Altun Ugur B, Kara M, Tugrul A. Complete relief of pain in acute painful diabetic neuropathy of rapid glycaemic control (insulin neuritis) with venlafaxine HCL. Diabetes Nutr Metab. 2004;17(4):247–9.
  9. Takayama S, Takahashi Y, Osawa M, Iwamoto Y. Acute painful neuropathy restricted to the abdomen following rapid glycaemic control in type 2 diabetes. J Int Med Res. 2004;32(5):558–62.
  10. Dabby R, Sadeh M, Lampl Y, Gilad R, Watemberg N. Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients. Biomed Pharmacother. 2009;63(10):707–9.
  11. Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol. 2010;67(4):534–41.
  12. Ellenberg M. Diabetic neuropathic cachexia. Diabetes. 1974;23(5): 418–23.
  13. Weintrob N, Josefsberg Z, Galazer A, Vardi P, Karp M. Acute painful neuropathic cachexia in a young type I diabetic woman. A case report. Diabetes Care. 1997;20(3):290–1.
  14. Wright DL, Shah JH. Diabetic neuropathic cachexia and hypothyroidism in a woman. Mo Med. 1987;84(3):143–5.
  15. Blau RH. Diabetic neuropathic cachexia. Report of a woman with this syndrome and review of the literature. Arch Intern Med. 1983;143(10):2011–2.
  16. Huber CA, Schwenkglenks M, Rapold R, Reich O. Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011. BMC Endocr Disord. 2014;14:44.
  17. Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain. 2015;138(Pt 1):43–52.
  18. Massey EW. Diabetic neuropathic cachexia and diabetic amyotrophy. Acta Diabetol Lat. 1982;19(1):91–5.
  19. Blau RH. Diabetic neuropathic cachexia. Report of a woman with this syndrome and review of the literature. Arch Intern Med. 1983;143(10):2011–2.
  20. Al-Hajeri T, El-Gebely S, Abdella N. Profound weight loss in a type 2 diabetic patient with diabetic neuropathic cachexia: a case report. Diabetes Metab. 2009;35(5):422–4.
  21. Gade GN, Hofeldt FD, Treece GL. Diabetic neuropathic cachexia. Beneficial response to combination therapy with amitriptyline and fluphenazine. JAMA. 1980;243(11):1160–1.
  22. Jackson CE, Barohn RJ. Diabetic neuropathic cachexia: report of a recurrent case. J Neurol Neurosurg Psychiatry. 1998;64(6):785–7.
  23. D’Costa DF, Price DE, Burden AC. Diabetic neuropathic cachexia associated with malabsorption. Diabet Med. 1992;9(2):203–5.
  24. Song KB, Cho SJ, Minn YK, Kwon KH, Park MK. A case of insulin neuritis that developed in a patient under regular insulin treatment on increasing the insulin dose. Insulin neuritis: is it a misnomer? J Neurol. 2009;256(2):274–5.
  25. Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry. 1983;46(6):491–9.
  26. Godil A, Berriman D, Knapik S, Norman M, Godil F, Firek AF. Diabetic neuropathic cachexia. West J Med. 1996;165(6):382–5.
  27. Castellanos F, Mascias J, Zabala JA, Ricart C, Cabello A, Garcia-Merino A. Acute painful diabetic neuropathy following severe weight loss. Muscle Nerve. 1996;19(4):463–7.
  28. Standards of medical care in diabetes – 2015: summary of revisions. Diabetes Care. 2015;38 Suppl:S4.
  29. Tesfaye S. Recent advances in the management of diabetic distal symmetrical polyneuropathy. J Diabetes Investig. 2011;2(1):33–42.
  30. Seneviratne U, Gunasekera S. Acute small fibre sensory neuropathy: another variant of Guillain-Barré syndrome? J Neurol Neurosurg Psychiatry. 2002;72(4):540–2.
  31. Dabby R, Gilad R, Sadeh M, Lampl Y, Watemberg N. Acute steroid responsive small-fiber sensory neuropathy: a new entity? J Peripher Nerv Syst. 2006;11(1):47–52.
  32. Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain. 1999;81(1–2):135–45.
  33. Kennedy WR, Wendelschafer-Crabb G. Utility of skin biopsy in diabetic neuropathy. Semin Neurol. 1996;16(2):163–71.
  34. Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia. 1996;39(3):329–35.
  35. Kihara M, Zollman PJ, Smithson IL, Lagerlund TD, Low PA. Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve. Am J Physiol. 1994;266(6 Pt 1):E980–5.
  36. Eaton SE, Harris ND, Ibrahim S, Patel KA, Selmi F, Radatz M, et al. Increased sural nerve epineurial blood flow in human subjects with painful diabetic neuropathy. Diabetologia. 2003;46(7):934–9.
  37. Leow MK, Wyckoff J. Under-recognised paradox of neuropathy from rapid glycaemic control. Postgrad Med J. 2005;81(952):103–7.
  38. Uçeyler N, Sommer C. Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci Lett. 2008;437(3):194–8.
  39. Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010;17(8):1010–8.
  40. England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72(2):185–92.
  41. Ragé M, Van Acker N, Knaapen MW, Timmers M, Streffer J, Hermans MP, et al. Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials. J Neurol. 2011;258(10):1852–64.
  42. Onal MR, Ulas UH, Oz O, Bek VS, Yucel M, Taslipinar A, et al. Cutaneous silent period changes in Type 2 diabetes mellitus patients with small fiber neuropathy. Clin Neurophysiol. 2010;121(5):714–8.
  43. Koytak PK, Isak B, Borucu D, Uluc K, Tanridag T, Us O. Assessment of symptomatic diabetic patients with normal nerve conduction studies: utility of cutaneous silent periods and autonomic tests. Muscle Nerve. 2011;43(3):317–23.
  44. Devigili G, Tugnoli V, Penza P, Camozzi F, Lombardi R, Melli G, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain. 2008;131(Pt 7):1912–25.
  45. Zhao C, Lu S, Truffert A, Tajouri N, Zhao K, Mateo Montoya A, et al. Corneal nerves alterations in various types of systemic polyneuropathy, identified by in vivo confocal microscopy. Klin Monbl Augenheilkd. 2008;225(5):413–7.
  46. Edwards K, Pritchard N, Vagenas D, Russell A, Malik RA, Efron N. Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study. Clin Exp Optom. 2012;95(3):348–54.
  47. Tavakoli M, Petropoulos IN, Malik RA. Corneal confocal microscopy to assess diabetic neuropathy: an eye on the foot. J Diabetes Sci Technol. 2013;7(5):1179–89.
  48. Nitoda E, Kallinikos P, Pallikaris A, Moschandrea J, Amoiridis G, Ganotakis ES, et al. Correlation of diabetic retinopathy and corneal neuropathy using confocal microscopy. Curr Eye Res. 2012;37(10):898–906.
  49. Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008;9(6):660–74.
  50. Hartemann A, Attal N, Bouhassira D, Dumont I, Gin H, Jeanne S, et al. Painful diabetic neuropathy: diagnosis and management. Diabetes Metab. 2011;37(5):377–88.
  51. Boulton AJ, Drury J, Clarke B, Ward JD. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care. 1982;5(4):386–90.
  52. Oyibo SO, Prasad YD, Jackson NJ, Jude EB, Boulton AJ. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med. 2002;19(10):870–3.
  53. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–62.
  54. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977–86.
  55. Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–59.
  56. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–39.

Most read articles by the same author(s)